Published in Cardiovasc Res on November 30, 2010
Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38
Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet (2012) 1.09
Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet (2013) 0.92
Novel GATA5 loss-of-function mutations underlie familial atrial fibrillation. Clinics (Sao Paulo) (2012) 0.84
New advances in the genetic basis of atrial fibrillation. J Cardiovasc Electrophysiol (2012) 0.84
Ion Channels in the Heart. Compr Physiol (2015) 0.83
Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation. Clinics (Sao Paulo) (2013) 0.83
PITX2C loss-of-function mutations responsible for idiopathic atrial fibrillation. Clinics (Sao Paulo) (2014) 0.80
Mutational spectrum of the NKX2-5 gene in patients with lone atrial fibrillation. Int J Med Sci (2014) 0.79
A KCNQ1 mutation causes age-dependant bradycardia and persistent atrial fibrillation. Pflugers Arch (2013) 0.78
Single-nucleotide variations in cardiac arrhythmias: prospects for genomics and proteomics based biomarker discovery and diagnostics. Genes (Basel) (2014) 0.78
Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation. Basic Res Cardiol (2015) 0.78
Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillation. Basic Res Cardiol (2016) 0.77
Personalized medicine and atrial fibrillation: will it ever happen? BMC Med (2012) 0.76
Destruction Of Medium Already Afected By Destructive Disorder: Fibrillating Atria Conceptually Need Therapeutic Help Rather Than Surgical Or Ablative Destruction. J Atr Fibrillation (2014) 0.75
Cardiac Delayed Rectifier Potassium Channels in Health and Disease. Card Electrophysiol Clin (2016) 0.75
Association between KCNE1 G38S gene polymorphism and risk of atrial fibrillation: A PRISMA-compliant meta-analysis. Medicine (Baltimore) (2017) 0.75
Common genetic variation and human traits. N Engl J Med (2009) 21.03
Rare variants create synthetic genome-wide associations. PLoS Biol (2010) 14.43
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med (1995) 6.49
Natriuretic peptides. N Engl J Med (1998) 6.04
New ideas about atrial fibrillation 50 years on. Nature (2002) 5.84
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med (2002) 5.55
Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell (2003) 5.05
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Identification of a genetic locus for familial atrial fibrillation. N Engl J Med (1997) 4.66
Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA (2005) 3.89
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med (2006) 3.59
Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation. Circ Res (2001) 3.36
Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet (2006) 3.15
Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol (1988) 3.14
Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol (2003) 3.09
Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation (2004) 3.02
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Cardiac conduction defects associate with mutations in SCN5A. Nat Genet (1999) 2.73
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet (2004) 2.66
Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J Physiol (2000) 2.59
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun (2005) 2.55
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Structural correlate of atrial fibrillation in human patients. Cardiovasc Res (2002) 2.55
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res (2001) 2.41
Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol (2005) 2.39
Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome. J Gen Physiol (1998) 2.37
Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res (1999) 2.37
Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm (2006) 2.30
Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation (2003) 2.28
De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27
Familial aggregation of atrial fibrillation in Iceland. Eur Heart J (2006) 2.27
Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res (1997) 2.26
A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther (2007) 2.17
A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res (2003) 2.15
Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med (2008) 2.14
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol (2001) 2.13
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J (2008) 2.10
An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Am J Physiol Heart Circ Physiol (2008) 2.09
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation (2003) 2.03
Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm (2008) 2.01
Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J (2005) 1.96
Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci U S A (1996) 1.93
A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet (2009) 1.87
Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation. Heart Rhythm (2009) 1.87
Inward rectifiers in the heart: an update on I(K1). J Mol Cell Cardiol (2001) 1.84
Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand (1971) 1.83
Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J (2006) 1.82
Status of the epidemiology of atrial fibrillation. Med Clin North Am (2008) 1.80
Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle. FASEB J (1991) 1.71
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks). J Mol Cell Cardiol (2005) 1.70
Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest (2005) 1.70
Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell (2008) 1.70
In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart. Cardiovasc Res (2005) 1.68
Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation (2005) 1.67
Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol (2007) 1.67
Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J (1983) 1.61
Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both? J Cardiovasc Electrophysiol (1998) 1.60
Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res (2004) 1.59
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 1.56
Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation (1998) 1.50
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.49
Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart (2004) 1.45
Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J (2002) 1.43
The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz (2000) 1.42
High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol (2005) 1.40
Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J (2004) 1.38
Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation (2001) 1.37
Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet (2003) 1.37
Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovasc Res (2005) 1.36
Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res (1993) 1.35
The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol (2001) 1.30
Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2. J Physiol (2003) 1.30
M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit. FEBS Lett (2000) 1.29
The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol (2006) 1.28
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm (2008) 1.27
A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett (2000) 1.25
The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation (2001) 1.24
A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol (2008) 1.22
Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels. J Physiol (2008) 1.22
Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol (2002) 1.21
Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation (2004) 1.21
Atrial fibrillation in KCNE1-null mice. Circ Res (2005) 1.21
Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med Genet (2006) 1.21
Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol (2003) 1.20
Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet (2009) 1.17
Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res (2005) 1.13
IK1 heterogeneity affects genesis and stability of spiral waves in cardiac myocyte monolayers. Circ Res (2009) 1.07
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm (2007) 3.23
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21
High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol (2005) 2.64
Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol (2004) 2.57
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest (2008) 2.39
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). Am J Cardiol (2011) 2.39
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation (2011) 2.36
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation (2010) 2.32
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol (2006) 2.29
Adenosine for wide-complex tachycardia: efficacy and safety. Crit Care Med (2009) 2.10
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. JAMA (2008) 2.09
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation (2009) 1.99
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med (2012) 1.97
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation (2010) 1.90
Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation. Heart Rhythm (2009) 1.87
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm (2011) 1.85
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol (2006) 1.77
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA (2010) 1.75
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J (2005) 1.71
Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol (2010) 1.70
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2006) 1.68
Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation (2007) 1.67
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation (2012) 1.67
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm (2010) 1.66
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation (2012) 1.65
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet (2010) 1.57
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Heart Rhythm (2009) 1.55
Genome-wide association studies of the PR interval in African Americans. PLoS Genet (2011) 1.53
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice. Heart Rhythm (2010) 1.45
Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med (2007) 1.41
Case records of the Massachusetts General Hospital. Case 37-2005. A 35-year-old man with cardiac arrest while sleeping. N Engl J Med (2005) 1.38
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing. Pharmacogenomics (2009) 1.37
P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol (2009) 1.35
Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet (2010) 1.33
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation (2012) 1.32
Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res (2011) 1.27
Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol (2011) 1.22
Overexpression of KCNN3 results in sudden cardiac death. Cardiovasc Res (2013) 1.21
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation (2012) 1.17
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol (2012) 1.17
Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2007) 1.17
Genetics of atrial fibrillation. Heart Fail Clin (2010) 1.15
Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr (2010) 1.15
Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.12
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol (2010) 1.12
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.09
An update on the prognosis of patients with atrial fibrillation. Circulation (2012) 1.09